MyD88‐dependent autoimmune disease in Lyn‐deficient mice

KL Silver, TL Crockford… - European journal of …, 2007 - Wiley Online Library
KL Silver, TL Crockford, T Bouriez‐Jones, S Milling, T Lambe, RJ Cornall
European journal of immunology, 2007Wiley Online Library
Recent evidence suggests that systemic autoimmune disease depends on signals from TLR
ligands, but little is known about how TLR‐dependent pathways lead to the loss of self
tolerance in vivo. To address this, we have examined the role of TLR signaling in Lyn‐
deficient mice, which develop an autoimmune disease similar to SLE. We found that
absence of the TLR signaling adaptor molecule MyD88 suppresses plasma cell
differentiation of switched and unswitched B cells, and prevents the generation of …
Abstract
Recent evidence suggests that systemic autoimmune disease depends on signals from TLR ligands, but little is known about how TLR‐dependent pathways lead to the loss of self tolerance in vivo. To address this, we have examined the role of TLR signaling in Lyn‐deficient mice, which develop an autoimmune disease similar to SLE. We found that absence of the TLR signaling adaptor molecule MyD88 suppresses plasma cell differentiation of switched and unswitched B cells, and prevents the generation of antinuclear IgG antibodies and glomerulonephritis. In mixed chimeras the increased IgM and IgG antibody secretion in Lyn‐deficient mice is at least partially due to B cell‐independent effects of Lyn. We now show that MyD88 deficiency blocks the expansion and activation of DC in which Lyn is also normally expressed, and prevents the hypersecretion of proinflammatory cytokines IL‐6 and IL‐12 by Lyn‐deficient DC. These findings further highlight the important role of TLR‐dependent signals in both lymphocyte activation and autoimmune pathogenesis.
Wiley Online Library